Certa Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 5

Certa Therapeutics General Information

Description

Developer of targeted drug therapies designed to treat inflammatory and fibrotic diseases. The company develops drugs that target biological pathways involved in fibrosis and uses genetic analysis to identify patients who are more likely to benefit from treatment, enabling healthcare professionals to select potential treatments for conditions such as chronic kidney disease and systemic sclerosis.

Contact Information

Website
www.certatherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Level 9, 31 Queen Street
  • Melbourne, Victoria 3000
  • Australia
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Level 9, 31 Queen Street
  • Melbourne, Victoria 3000
  • Australia

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Certa Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 01-Mar-2026 Completed Clinical Trials - Phase 2
4. Early Stage VC 01-Dec-2022 Completed Clinical Trials - Phase 2
3. Early Stage VC Completed Clinical Trials - Phase 2
2. Early Stage VC $86.3K $18.9M Completed Clinical Trials - Phase 2
1. Early Stage VC 04-Jun-2018 $18.8M $18.8M Completed Clinical Trials - Phase 2
To view Certa Therapeutics’s complete valuation and funding history, request access »

Certa Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
APRF
To view Certa Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Certa Therapeutics Patents

  • 48

    Total Documents Applications and Grants

  • Total Patents Families

  • 22

    Granted

  • 11

    Pending

  • Expiring in next 12 mo

Certa Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024900224-A0 Proton sensing gpcr modulators Inactive 01-Feb-2024
WO-2025160628-A1 Proton sensing gpcr modulators Pending 01-Feb-2024
AU-2024900217-A0 Proton sensing gpcr modulators Inactive 31-Jan-2024
WO-2025160629-A1 Proton sensing gpcr modulators Pending 31-Jan-2024
AU-2024423941-A1 Methods of treating scleroderma Pending 29-Jan-2024 A61K31/196
To view Certa Therapeutics’s complete patent history, request access »

Certa Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Brandon Capital Venture Capital Minority
Brandon Biocatalyst Venture Capital Minority
Shire (Pharmaceuticals) Corporation Minority
Stoic Venture Capital Venture Capital Minority
Uniseed Venture Capital Minority
To view Certa Therapeutics’s complete investors history, request access »

Certa Therapeutics Acquisitions (1)

Certa Therapeutics’s most recent deal was a Merger/Acquisition with OccuRx. The deal was made on 19-Dec-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
OccuRx 19-Dec-2024 Merger/Acquisition Drug Discovery
To view Certa Therapeutics’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Certa Therapeutics FAQs

  • When was Certa Therapeutics founded?

    Certa Therapeutics was founded in 2018.

  • Where is Certa Therapeutics headquartered?

    Certa Therapeutics is headquartered in Melbourne, Australia.

  • What industry is Certa Therapeutics in?

    Certa Therapeutics’s primary industry is Drug Discovery.

  • Is Certa Therapeutics a private or public company?

    Certa Therapeutics is a Private company.

  • What is Certa Therapeutics’s current revenue?

    The current revenue for Certa Therapeutics is .

  • How much funding has Certa Therapeutics raised over time?

    Certa Therapeutics has raised $19.1M.

  • Who are Certa Therapeutics’s investors?

    Brandon Capital, Brandon Biocatalyst, Shire (Pharmaceuticals), Stoic Venture Capital, and Uniseed have invested in Certa Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process